Atherosclerosis and lupus

Rheumatology

Volumn 43, Issue 8, 2004, Pages 943-945

  Gorman, C ^a   Isenberg, D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LIPID; STEROID;

ATHEROGENESIS; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CAUSE OF DEATH; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; EDITORIAL; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MORBIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTERIOSCLEROSIS; BLOOD; CAROTID ARTERY DISEASE; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; CAROTID ARTERY DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; LIPIDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS;

EID: 4344668942     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh217     Document Type: Editorial

References (29)

1. Urowitz MB, Bookman AAM, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of SLE. Am J Med 1976;60:221-5.
2. Aranow C, Ginzler EM. Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 2000;9:166-9.
3. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-9.
4. Manzi S, Meilahn EN, Rairie JE et al. Age-specific rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997;145:408-15.
5. Manzi S. Systemic lupus erythernatosus: a model for atherogenesis? Rheumatology 2000;39:353-9.
6. Petri M, Roubenoff R, Dallal GE, Madeau MR, Selhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996;348:1120-4.
7. Liang M, Mandl LA, Costenbader K, Fox E, Karlson E. Atherosclerotic vascular disease in systemic lupus erythematosus. J Natl Med Assoc 2002;94:813-9.
8. Esdaille JM, Abraharnowicz M, Grodzicky T et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
9. Hochberg MC, Petri M. The association of corticosteroid (CS) therapy with coronary heart disease (CHD) in patients with systemic lupus erythernatosus (SLE): a meta-analysis. Arthritis Rheum 1991; 34:R24.
10. Doria A, Shoenfeld Y, Wu R et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003;62:1071-7.
11. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
12. Mason JC. Statins and their role in vascular protection. Clin Sci 2003;105:251-66.
13. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
14. Manzi S, Selzer F, Sutton-Tyrell K et al. Prevalence and risk factors of carotid plaque in systemic lupus erythematosus. Arthritis Rheum 1999;42:51-60.
15. Manger K, Kusus M, Forster C et al. Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis 2003;62:846-50.
16. Sella EMC, Sato EI, Leite WA, Oliveira Filho JA, Barbieri A. Myocardial perfusion scintigraphy and coronary disease in risk factors in systemic lupus erythematosus. Ann Rheum Dis 2003;62:1066-70.
17. Theodoriou A, Bento L, D'Cruz DP, Kharnashta MA, Hughes GRV. Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis 2003;62:1199-203.
18. Lima DSN, Sato EI, Lima VC, Miranda F, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002;29:292-7.
19. Selzer F, Sutton-Tyrell K, Fitzgerald S, Tracy R, Kuller L, Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001;37:1075-82.
20. Constans J, Dupuy R, Blann AD et al. Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus. J Rheumatol 2003;30:1963-6.
21. Delgado-Alves J, Ames PRJ. Atherosclerosis, oxidative stress and autoantibodies in systemic lupus erythematosus and primary antiphospholipid syndrome. Immunobiology 2003;207:23-8.
22. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T. Cross-reaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993;341:923-5.
23. Puurunen M, Mantarri M, Manninen V et al. Antibody against oxidised low-density lipoprotein predicting myocardial infarction. Arch Intern Med 1994;154:2605-9.
24. Delgado-Alves J, Kumar S, Isenberg DA. Cross-reaction between anti-cardiolipin, anti-high-density lipoprotein and antiapolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 2003;42:893-9.
25. Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JPA, Tektonidou MG, Mastorakou I, Moutsopoulos HM. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology 2003;42:645-51.
26. Delgado-Alves J, Ames PR, Donohue S et al. Antibodies to highdensity lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 2002;46:2686-94.
27. Svenungusson E, Fei GZ, Jensen-Urstad K, de Faire U, Hamsten A, Frostegard J. TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. Lupus 2003;12:454-61.
28. Roman MJ, Shanker B, Davis A et al. Prevalence-and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
29. Asanuma Y, Oeser A, Shintani AK et al. Premature coronary artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407-15.